Add like
Add dislike
Add to saved papers

Incontinence associated with bilateral lesions of putamen.

Archives of Neurology 1989 Februrary
From 1238 postmortem brain examinations, 44 subject cases with bilateral putamen lesions and 44 controls without bilateral putamen lesions were chosen and compared for the presence and severity of incontinence. The lesions were divided into three grades and the incontinence into five degrees of severity. Final results revealed that 39 of 44 subject cases had some degree of fecal incontinence compared with 12 of 44 controls. The subject cases included 14 with degree 4 incontinence while the controls had none. Forty-three of 44 subject cases exhibited urinary incontinence compared with 25 of 44 controls with the degree again being more severe in the subject cases. Using the chi 2 test, the probability that these differences were due to chance is minimal. Therefore, bilateral putamen involvement appears to be a significant factor in the occurrence of incontinence, and further study of this association is indicated.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app